New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 26, 2014
09:03 EDTICPTIntercept thesis unchanged with pushed out data, says Summer Street
Summer Street said it sees no reason to change its thesis on shares of Intercept after the company said the FLINT data is likely to be released in August, from July previously. The firm believes the data could represent a "significant positive catalyst" for the stock, and it thinks the potential for breakthrough designation on positive data remains a "very real possibility." Summer Street reiterates a Buy rating on Intercept with a $650 price target.
News For ICPT From The Last 14 Days
Check below for free stories on ICPT the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
August 28, 2014
17:05 EDTICPTOrbiMed reports 7% stake in Intercept
Subscribe for More Information
August 26, 2014
07:46 EDTICPTIntercept Pharmaceuticals volatility at low end of historic range
Subscribe for More Information
August 18, 2014
10:57 EDTICPTOptions with decreasing implied volatility
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use